A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
1 other identifier
observational
10,885
1 country
10
Brief Summary
The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 30, 2018
CompletedFirst Posted
Study publicly available on registry
February 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedMay 21, 2018
May 1, 2018
Same day
January 30, 2018
May 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
Overall survival
2015-2017
Other Outcomes (4)
Overall survivals in the subgroups
2015-2017
Impact factors of overall survival
2015-2017
Death rate within 30/90 days after surgeries
2015-2017
- +1 more other outcomes
Study Arms (1)
Patients with surgeries
Pathologically diagnosed elderly early Chinese patients with non-small cell lung cancer who received lobectomy or segment/wedge dissection
Interventions
Eligibility Criteria
Pathological diagnosed elderly Chinese patients with non-small cell lung cancer who received lobectomy or segment/wedge dissection
You may qualify if:
- Patients who received surgeries from 2014 to 2017;
- Patients who received lobectomy or segment/wedge dissection;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Patients with age \>=65 years old.
You may not qualify if:
- Patients who received neoadjuvant therapy prior to surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
China People's Liberation Army Hospital
Beijing, Beijing Municipality, 100853, China
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, 430030, China
Jiangsu Cancer Hospital
Nanjing, Jiangsu, 210009, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, 710000, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
Huaxi Hospital Affiliate to Sichuan University
Chengdu, Sichuan, 610041, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, 300051, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, 310003, China
Related Publications (1)
Zhang Z, Feng H, Zhao H, Hu J, Liu L, Liu Y, Li X, Xu L, Li Y, Lu X, Fu X, Yang H, Liu D. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis. 2019 May;11(5):1838-1848. doi: 10.21037/jtd.2019.05.20.
PMID: 31285876DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 30, 2018
First Posted
February 12, 2018
Study Start
December 1, 2017
Primary Completion
December 1, 2017
Study Completion
March 30, 2018
Last Updated
May 21, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share